RecruitingNot ApplicableNCT05407168

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool


Sponsor

OHSU Knight Cancer Institute

Enrollment

300 participants

Start Date

Oct 31, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria6

  • AIM 1: Suspected lung cancer
  • AIM 1: English fluency
  • AIM 1: \> 6-month life expectancy
  • AIM 1: Score of ≥ 3 on the cognitive impairment screener
  • AIM 2 PARTICIPANTS: Participation in Aim 1
  • AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Interventions

OTHERBest Practice

Receive standard of care

OTHERHealth Promotion and Education

View decision aid

OTHERQuestionnaire Administration

Ancillary studies


Locations(4)

Hillsboro Medical Center

Hillsboro, Oregon, United States

Adventist Health Portland

Portland, Oregon, United States

OHSU Knight Cancer Institute

Portland, Oregon, United States

Portland VA Medical Center

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05407168


Related Trials